1
Total investments
0
Early stage
1
Mid stage
0
Late stage
3y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
Dec 2023
We invest in founders who are reshaping outdated industries.
We believe in a world where top tier fintech products help the 99% grow their wealth and build businesses.
Where everyday people have transparent, efficient, and attentive healthcare experiences.
Where managers and front-line employees in legacy industries have tools that save time, increase transparency, and take minutes to learn (vertical SaaS).
Experience · 2 entries
All (2)
Investments (1)
2023
Angel Investor
Dec 2023
We invest in founders who are reshaping outdated industries.
We believe in a world where top tier fintech products help the 99% grow their wealth and build businesses.
Where everyday people have transparent, efficient, and attentive healthcare experiences.
Where managers and front-line employees in legacy industries have tools that save time, increase transparency, and take minutes to learn (vertical SaaS).
2021
Associate Director, Healthcare Strategy
Jun 2021
Created out of a need for more transparent quality and competency standards in the biopharma space, the Accreditation Council for Medical Affairs (ACMA) has evolved into the only independent accrediting body overseeing the life sciences industry. Founded in 2015 by its CEO, Dr. William Soliman, PhD., the ACMA works across the industry to credential individuals and accredit the practices of various companies operating in the arena.
Today, the ACMA works with Industry, Regulators, and Academia, among others, to further its mission: Establishing Best-in-Class Practices across the Life Sciences Industry to ensure the most rigorous quality/competency standards are established and globally enforced to elevate patient care